| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/27/2007 | CN1322852C Huodan dripping pills for treating rhinitis and its preparing process |
| 06/27/2007 | CN1322851C Tripterygium total terpenoids drop pill and its preparing method |
| 06/27/2007 | CN1322850C Nicardipine hydro-chloride powder injection and its preparing method |
| 06/27/2007 | CN1322824C Buccal tablet of flower or flower extract |
| 06/26/2007 | USRE39706 Crystalline form of a vitamin D analogue |
| 06/26/2007 | US7236820 Standardized swallow challenge medium and method of use for esophageal function testing |
| 06/26/2007 | US7235685 Of tumors and other lesions; phototherapeutic effect is caused by direct interaction of free radicals, the reactive intermediate produced upon photofragmentation of the sulfenate moiety, with the tissue of interest |
| 06/26/2007 | US7235536 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prophylaxis of fungal infection |
| 06/26/2007 | US7235535 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 06/26/2007 | US7235527 Polypeptide for use in the treatment bone disorders and osteoarthritis |
| 06/26/2007 | US7235524 Luteinizing hormone in an administrable form which ensures an increase in plasma levels for 40-60 hours |
| 06/26/2007 | US7235522 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 06/26/2007 | US7235391 Bulking agents, cryoprotectants and lyoprotectants added for storage stability |
| 06/26/2007 | US7235261 Encapsulated dry powder; mixture of polymer, silica, corn starch and perfume; spray drying |
| 06/26/2007 | US7235260 Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor |
| 06/26/2007 | US7235259 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 06/26/2007 | US7235258 a core containing a compressed mixture of the therapeutically effective unit dose of the active isovaleric acid or salt, ester or isovaleramides, and a xanthan gum matrix, a film-coating of a mixture of ethyl cellulose and hydroxypropylmethyl cellulsoe around the core; epilepsy, spasticity, migraine |
| 06/26/2007 | US7235257 Drugs for relieving hemicrania comprising 1-menthol and essential oils |
| 06/26/2007 | US7235253 Stabilization by adding to the aqueous liquid at least one compound selected from the group consisting of a nonionic surfactant, a water-soluble, nonionic, organic binder, hydrogenated lecithin, and mannitol. |
| 06/26/2007 | US7235248 Pharmaceutical compositions comprising cyclosporins |
| 06/26/2007 | US7235247 Aqueous solution; efficient penetration |
| 06/26/2007 | US7235237 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 06/26/2007 | US7235068 Having recess and rib for effecting a movable seal with the enclosure; osmotic agent imbibes liquid from a surrounding environment through a semipermeable body to cause the piston to move and in turn causing drug delivery |
| 06/26/2007 | US7234582 Coin guiding apparatus |
| 06/26/2007 | US7234290 Process for producing aspheric seamless capsule and apparatus therefor |
| 06/26/2007 | CA2494473C Stabilized protein compositions for topical administration and methods of making same |
| 06/26/2007 | CA2455231C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 06/26/2007 | CA2402791C Pre-formed sheet devices for topical application comprising a benefit agent coated solid gel sheet |
| 06/26/2007 | CA2379605C Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/26/2007 | CA2367414C An improved reversible contraceptive for male and female |
| 06/26/2007 | CA2269921C Ionophore-mediated liposome loading of weakly basic drug |
| 06/26/2007 | CA2186423C Protein which induces interferon-gamma production by immunocompetent cell |
| 06/22/2007 | CA2571276A1 Modified release formulation of lithium carbonate and method for the preparation thereof |
| 06/21/2007 | WO2007070875A1 Treatment of active infections and related compositions |
| 06/21/2007 | WO2007070851A2 Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration |
| 06/21/2007 | WO2007070843A2 Processes for making particle-based pharmaceutical formulations for oral administration |
| 06/21/2007 | WO2007070840A2 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 06/21/2007 | WO2007070695A2 Flux-enabling compositions and methods for dermal delivery of drugs |
| 06/21/2007 | WO2007070694A2 Spray-on formulations and methods for dermal delivery of drugs |
| 06/21/2007 | WO2007070679A2 Compositions and methods for dermally treating pain |
| 06/21/2007 | WO2007070643A2 Compositions and methods for treating dermatological conditions |
| 06/21/2007 | WO2007070632A2 Abuse resistant transmucosal drug delivery device |
| 06/21/2007 | WO2007070569A2 Composition and regimen for the treatment of epidermal herpetic lesions |
| 06/21/2007 | WO2007070504A2 Stable and palatable oral liquid sumatriptan compositions |
| 06/21/2007 | WO2007070503A2 Flexible wound dressing |
| 06/21/2007 | WO2007070168A2 Cosmetic compositions with encapsulated pigments and a method for using |
| 06/21/2007 | WO2007070115A1 Luminescent metallic cluster particles and uses thereof |
| 06/21/2007 | WO2007070082A1 Nanoparticulate and controlled release compositions comprising teprenone |
| 06/21/2007 | WO2007070052A2 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
| 06/21/2007 | WO2007069874A1 Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same |
| 06/21/2007 | WO2007069827A1 Pharmaceutical composition with extended release layer and fast release layer for treatment of hyperlipidemia and arteriosclerosis |
| 06/21/2007 | WO2007069662A1 Adhesive preparation |
| 06/21/2007 | WO2007069661A1 Bisoprolol-containing adhesive patch |
| 06/21/2007 | WO2007069378A1 Drug package |
| 06/21/2007 | WO2007069358A1 Novel preparation of gastric retention type |
| 06/21/2007 | WO2007069061A2 Controlled release compositions containing zolpidem |
| 06/21/2007 | WO2007068963A2 Therapeutic compositions comprising ingenol-3-angelate |
| 06/21/2007 | WO2007068948A2 Pharmaceutical sustained release compositions comprising in particular thyroid hormones |
| 06/21/2007 | WO2007068829A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/21/2007 | WO2007068701A1 Aqueous-alcoholic depigmenting gel |
| 06/21/2007 | WO2007068615A2 Hcv prodrug formulation |
| 06/21/2007 | WO2007068492A1 Medicinal composition with active ingredients and wound contact layer with a composition |
| 06/21/2007 | WO2007068491A1 Medicinal composition and wound contact layer comprising a composition |
| 06/21/2007 | WO2007068490A1 Antimicrobial wound contact layer |
| 06/21/2007 | WO2007068443A1 Powder compositions for inhalation |
| 06/21/2007 | WO2007068287A1 Sustained release vitamin preparation |
| 06/21/2007 | WO2007068212A1 Intravenous emulsion of butylbenzene phthalein and its application |
| 06/21/2007 | WO2007068086A1 Emulsion-containing medical articles |
| 06/21/2007 | WO2007053514A3 Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage |
| 06/21/2007 | WO2007050697A3 Compositions and methods for the administration psychotropic drugs which modulate body weight |
| 06/21/2007 | WO2007036278A8 Method for stabilising pharmaceutical administration forms that contain micro-organisms |
| 06/21/2007 | WO2007035816A3 Paroxetine compositions |
| 06/21/2007 | WO2007031621B1 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 06/21/2007 | WO2007031620B1 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 06/21/2007 | WO2007028512A3 Magnetic-field controlled active substance transfer for aerosol therapy |
| 06/21/2007 | WO2007018954A3 Application of a bioactive agent in a solvent composition to produce a target particle morphology |
| 06/21/2007 | WO2007018887A3 Application of a bioactive agent to a substrate |
| 06/21/2007 | WO2007014392A3 Benzoquinones of enhanced bioavailability |
| 06/21/2007 | WO2007011619A3 Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate |
| 06/21/2007 | WO2007009801A3 Oral, quickly disintegrating film, which cannot be spit out, for a neuroleptic drug |
| 06/21/2007 | WO2007002523A3 Collapsible patch with microneedle array |
| 06/21/2007 | WO2006124047A9 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| 06/21/2007 | WO2006119121A3 Cell-surface decoration with active agents |
| 06/21/2007 | WO2006105401A3 Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | WO2006099359A3 Methods of reducing microbial contamination |
| 06/21/2007 | WO2006094974B1 Chemically defined stabiliser composition |
| 06/21/2007 | WO2006079614A3 Copolyhydroxyalkylglutamines which are functionalised with hydrophobic groups and applications thereof, such as in therapeutics |
| 06/21/2007 | US20070142822 Method and Apparatus for Computer Controlled Metering of Liquid Medicaments in the Event of a Time Shift |
| 06/21/2007 | US20070142728 Apparatus and methods using acoustic telemetry for intrabody communications |
| 06/21/2007 | US20070142468 Compositions containing prodrugs of florfenicol and methods of use |
| 06/21/2007 | US20070142442 Stabilized pharmaceutical compositions containing a calcium channel blocker |
| 06/21/2007 | US20070142354 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/21/2007 | US20070142344 fluocinonide or fluocinonide acetonide topical with two or more penetration enhancers |
| 06/21/2007 | US20070142343 Mixture with penetration intensifiers, solvents and emulsifiers |
| 06/21/2007 | US20070142326 Treatment of a condition in a mammal with administration of aminosugar and uses thereof |
| 06/21/2007 | US20070142315 stimulate Toll-like receptor 8 (TLR8); drug delivery; cancer, an allergic condition, asthma, airway remodeling, or immunodeficiency |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070141694 Sequestering Of Glycoprotein Molecules and Oligosaccharide Moieties In Lipo-Glycoprotein Membranes and Micelles |